Science Journals In Leukaemia
Leukemia is a group of blood cancers that sometimes begin within the bone marrow and end in high numbers of abnormal blood cells. Diagnosis is usually made by blood tests or bone marrow biopsy. Treatment may involve some combination of chemotherapy,
radiotherapy , targeted therapy, and bone marrow transplant, additionally to supportive care and
palliative care as required. Because the bone marrow produces more
cancer cells, they start to overcrowd the blood, preventing the healthy white blood
cells from growing and functioning normally. In highly lethal sort of leukemia,
cancer gene predicts treatment response. Patients with the foremost lethal sort of acute chronic myelocytic
leukemia (AML) – supported genetic profiles of their cancers – typically survive for less than four to 6 months after diagnosis, even with aggressive chemotherapy.
High Impact List of Articles
-
Efficacy of a single fixed 131I dose of Radioactive iodine for the treatment of hyperthyroidism
Husain Taha Radhi*, Hasan Frookh Jamal*, Aysha Asif Sarwani*, Abdullah Jawad Jamal, Marwa Fiasal Al-Alawi, Abdullah Sanad Alsabea, Buthainah Ali Al-Azman, Zeenab Jaber Alsaleh
Research Article: Clinical Investigation
-
Efficacy of a single fixed 131I dose of Radioactive iodine for the treatment of hyperthyroidism
Husain Taha Radhi*, Hasan Frookh Jamal*, Aysha Asif Sarwani*, Abdullah Jawad Jamal, Marwa Fiasal Al-Alawi, Abdullah Sanad Alsabea, Buthainah Ali Al-Azman, Zeenab Jaber Alsaleh
Research Article: Clinical Investigation
-
Diabetic Kidney Disease: A stepwise approach to combat disease
Yusra Habib Khan* & Tauqeer Hussain Mallhi
Editorial: Diabetes Management
-
Diabetic Kidney Disease: A stepwise approach to combat disease
Yusra Habib Khan* & Tauqeer Hussain Mallhi
Editorial: Diabetes Management
-
A current and future look at the status of obesity research
Fary M Cachelin
Conference Report: Diabetes Management
-
A current and future look at the status of obesity research
Fary M Cachelin
Conference Report: Diabetes Management
-
European Society for Medical Oncology 2012 annual meeting: update on oncology trials
Christoph Zielinski
Interview: Clinical Investigation
-
European Society for Medical Oncology 2012 annual meeting: update on oncology trials
Christoph Zielinski
Interview: Clinical Investigation
-
New drug for Hepatitis C in Phase II trials
Bulletin Board: Clinical Practice
-
New drug for Hepatitis C in Phase II trials
Bulletin Board: Clinical Practice
Relevant Topics in Clinical